Cargando…

Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study

BACKGROUND: We aimed to examine the relationship between musculoskeletal deterioration and all‐cause mortality in a cohort of women studied prospectively over a decade. METHODS: A cohort of 750 women aged 50–94 years was followed for a decade after femoral neck bone mineral density (BMD) and appendi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasco, Julie A., Mohebbi, Mohammadreza, Holloway, Kara L., Brennan‐Olsen, Sharon L., Hyde, Natalie K., Kotowicz, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476862/
https://www.ncbi.nlm.nih.gov/pubmed/28025860
http://dx.doi.org/10.1002/jcsm.12177
_version_ 1783244680327069696
author Pasco, Julie A.
Mohebbi, Mohammadreza
Holloway, Kara L.
Brennan‐Olsen, Sharon L.
Hyde, Natalie K.
Kotowicz, Mark A.
author_facet Pasco, Julie A.
Mohebbi, Mohammadreza
Holloway, Kara L.
Brennan‐Olsen, Sharon L.
Hyde, Natalie K.
Kotowicz, Mark A.
author_sort Pasco, Julie A.
collection PubMed
description BACKGROUND: We aimed to examine the relationship between musculoskeletal deterioration and all‐cause mortality in a cohort of women studied prospectively over a decade. METHODS: A cohort of 750 women aged 50–94 years was followed for a decade after femoral neck bone mineral density (BMD) and appendicular lean mass (ALM) were measured using dual energy X‐ray absorptiometry, in conjunction with comorbidities, health behaviour data, and other clinical measures. The outcome was all‐cause mortality identified from the Australian National Deaths Index. Using Cox proportional hazards models and age as the time variable, mortality risks were estimated according to BMD groups (ideal‐BMD, osteopenia, and osteoporosis) and ALM groups (T‐scores > −1.0 high, −2.0 to −1.0 medium, <−2.0 low). RESULTS: During 6712 person years of follow‐up, there were 190 deaths, the proportions increasing with diminishing BMD: 10.7% (23/215) ideal‐BMD, 23.5% (89/378) osteopenia, 49.7% (78/157) osteoporosis; and with diminishing ALM: 17.0% (59/345) high, 26.2% (79/301) medium, 50.0% (52/104) low. In multivariable models adjusted for smoking, polypharmacy, and mobility, compared with those with ideal BMD, mortality risk was greater for those with osteopenia [hazard ratio (HR) 1.77, 95% confidence interval (CI) 1.11–2.81] and osteoporosis (HR 2.61, 95%CI 1.60–4.24). Similarly, compared with those with high ALM, adjusted mortality risk was greater for medium ALM (HR 1.36, 95%CI 0.97–1.91) and low ALM (HR 1.65, 95%CI 1.11–2.45). When BMD and ALM groups were tested together in the model, BMD remained a predictor of mortality (HR 1.74, 95%CI 1.09–2.78; HR 2.82, 95%CI 1.70–4.70; respectively), and low ALM had borderline significance (HR 1.52, 95%CI 1.00–2.31), which was further attenuated after adjusting for smoking, polypharmacy, and mobility. CONCLUSIONS: Poor musculoskeletal health increased the risk for mortality independent of age. This appears to be driven mainly by a decline in bone mass. Low lean mass independently exacerbated mortality risk, and this appeared to operate through poor health exposures.
format Online
Article
Text
id pubmed-5476862
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54768622017-06-23 Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study Pasco, Julie A. Mohebbi, Mohammadreza Holloway, Kara L. Brennan‐Olsen, Sharon L. Hyde, Natalie K. Kotowicz, Mark A. J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: We aimed to examine the relationship between musculoskeletal deterioration and all‐cause mortality in a cohort of women studied prospectively over a decade. METHODS: A cohort of 750 women aged 50–94 years was followed for a decade after femoral neck bone mineral density (BMD) and appendicular lean mass (ALM) were measured using dual energy X‐ray absorptiometry, in conjunction with comorbidities, health behaviour data, and other clinical measures. The outcome was all‐cause mortality identified from the Australian National Deaths Index. Using Cox proportional hazards models and age as the time variable, mortality risks were estimated according to BMD groups (ideal‐BMD, osteopenia, and osteoporosis) and ALM groups (T‐scores > −1.0 high, −2.0 to −1.0 medium, <−2.0 low). RESULTS: During 6712 person years of follow‐up, there were 190 deaths, the proportions increasing with diminishing BMD: 10.7% (23/215) ideal‐BMD, 23.5% (89/378) osteopenia, 49.7% (78/157) osteoporosis; and with diminishing ALM: 17.0% (59/345) high, 26.2% (79/301) medium, 50.0% (52/104) low. In multivariable models adjusted for smoking, polypharmacy, and mobility, compared with those with ideal BMD, mortality risk was greater for those with osteopenia [hazard ratio (HR) 1.77, 95% confidence interval (CI) 1.11–2.81] and osteoporosis (HR 2.61, 95%CI 1.60–4.24). Similarly, compared with those with high ALM, adjusted mortality risk was greater for medium ALM (HR 1.36, 95%CI 0.97–1.91) and low ALM (HR 1.65, 95%CI 1.11–2.45). When BMD and ALM groups were tested together in the model, BMD remained a predictor of mortality (HR 1.74, 95%CI 1.09–2.78; HR 2.82, 95%CI 1.70–4.70; respectively), and low ALM had borderline significance (HR 1.52, 95%CI 1.00–2.31), which was further attenuated after adjusting for smoking, polypharmacy, and mobility. CONCLUSIONS: Poor musculoskeletal health increased the risk for mortality independent of age. This appears to be driven mainly by a decline in bone mass. Low lean mass independently exacerbated mortality risk, and this appeared to operate through poor health exposures. John Wiley and Sons Inc. 2016-12-26 2017-06 /pmc/articles/PMC5476862/ /pubmed/28025860 http://dx.doi.org/10.1002/jcsm.12177 Text en © 2016 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Pasco, Julie A.
Mohebbi, Mohammadreza
Holloway, Kara L.
Brennan‐Olsen, Sharon L.
Hyde, Natalie K.
Kotowicz, Mark A.
Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study
title Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study
title_full Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study
title_fullStr Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study
title_full_unstemmed Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study
title_short Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study
title_sort musculoskeletal decline and mortality: prospective data from the geelong osteoporosis study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476862/
https://www.ncbi.nlm.nih.gov/pubmed/28025860
http://dx.doi.org/10.1002/jcsm.12177
work_keys_str_mv AT pascojuliea musculoskeletaldeclineandmortalityprospectivedatafromthegeelongosteoporosisstudy
AT mohebbimohammadreza musculoskeletaldeclineandmortalityprospectivedatafromthegeelongosteoporosisstudy
AT hollowaykaral musculoskeletaldeclineandmortalityprospectivedatafromthegeelongosteoporosisstudy
AT brennanolsensharonl musculoskeletaldeclineandmortalityprospectivedatafromthegeelongosteoporosisstudy
AT hydenataliek musculoskeletaldeclineandmortalityprospectivedatafromthegeelongosteoporosisstudy
AT kotowiczmarka musculoskeletaldeclineandmortalityprospectivedatafromthegeelongosteoporosisstudy